We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
High Tide Inc. (HITI) Suffers a Larger Drop Than the General Market: Key Insights
Read MoreHide Full Article
High Tide Inc. (HITI - Free Report) closed the latest trading day at $2.63, indicating a -1.87% change from the previous session's end. The stock trailed the S&P 500, which registered a daily loss of 0.27%. Elsewhere, the Dow saw a downswing of 0.51%, while the tech-heavy Nasdaq appreciated by 0.03%.
Shares of the company have depreciated by 13.27% over the course of the past month, underperforming the Medical sector's gain of 3.73% and the S&P 500's gain of 4.27%.
Investors will be eagerly watching for the performance of High Tide Inc. in its upcoming earnings disclosure. Simultaneously, our latest consensus estimate expects the revenue to be $95.97 million, showing a 1.28% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates project earnings of -$0.04 per share and a revenue of $413.24 million, demonstrating changes of 0% and +8.39%, respectively, from the preceding year.
It is also important to note the recent changes to analyst estimates for High Tide Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, there's been a 400% fall in the Zacks Consensus EPS estimate. At present, High Tide Inc. boasts a Zacks Rank of #5 (Strong Sell).
The Medical - Products industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 76, placing it within the top 31% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow HITI in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
High Tide Inc. (HITI) Suffers a Larger Drop Than the General Market: Key Insights
High Tide Inc. (HITI - Free Report) closed the latest trading day at $2.63, indicating a -1.87% change from the previous session's end. The stock trailed the S&P 500, which registered a daily loss of 0.27%. Elsewhere, the Dow saw a downswing of 0.51%, while the tech-heavy Nasdaq appreciated by 0.03%.
Shares of the company have depreciated by 13.27% over the course of the past month, underperforming the Medical sector's gain of 3.73% and the S&P 500's gain of 4.27%.
Investors will be eagerly watching for the performance of High Tide Inc. in its upcoming earnings disclosure. Simultaneously, our latest consensus estimate expects the revenue to be $95.97 million, showing a 1.28% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates project earnings of -$0.04 per share and a revenue of $413.24 million, demonstrating changes of 0% and +8.39%, respectively, from the preceding year.
It is also important to note the recent changes to analyst estimates for High Tide Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, there's been a 400% fall in the Zacks Consensus EPS estimate. At present, High Tide Inc. boasts a Zacks Rank of #5 (Strong Sell).
The Medical - Products industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 76, placing it within the top 31% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow HITI in the coming trading sessions, be sure to utilize Zacks.com.